Prospective Clinical Evaluation of Three Prosthesis Re-cap, M2a-Magnum and C2a-taper.

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00284674

Enrollment

Unknown

Registered

2006-02-01

Start date

2006-03-31

Completion date

Unknown

Last updated

2017-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing a THR

Brief summary

This evaluation is being conducted to evaluate the performance of thee prosthesis.

Interventions

DEVICEHip prosthesis (re-cap, m2a-magnum and C2a-taper)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Good general health of age (ASA I-II) * DEXA-scanning: lower limit for a 55 years old man * MRI normal vitality in caput * Willing to return for follow-up evaluations *

Exclusion criteria

* Subjects displaying any of the following contra-indications shall be excluded from this evaluation: * Inability to co-operate with and complete the study * Collum \< 2 cm * Large cysts in caput * Mismatch between caput acetabulum * Caput necrosis

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026